Extracellular matrix expression by equine oral and limb fibroblasts in in vitro culture

Research in Veterinary Science

Volumn 92, Issue 2, 2012, Pages 213-218

  Watts, Emma J ^a   Rose, Michael T ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

Equine; Extracellular matrix; Exuberant granulation tissue; Fibroblast; Transforming growth factor 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; DECORIN; FIBROMODULIN; FIBRONECTIN; MESSENGER RNA; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST CULTURE; HORSE; IN VITRO STUDY; LIMB; MOUTH MUCOSA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA SYNTHESIS; UPREGULATION;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; EXTREMITIES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HORSES; MOUTH MUCOSA; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EQUIDAE;

EID: 84856563444     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.03.020     Document Type: Article

References (33)

1. Agren M.S., Werthen M. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds. International Journal of Low Extremity Wounds 2007, 6:82-97.
2. Birk D.E., Mayne R. Localization of collagen types I, III and V during tendon development. Changes in collagen types I and III are correlated with changes in fibril diameter. European Journal of Cell Biology 1997, 72:352-361.
3. Bullard K.M., Longaker M.T., Lorenz H.P. Fetal wound healing: current biology. World Journal of Surgery 2003, 27:54-61.
4. Chin G.S., Liu W., Peled Z., Lee T.Y., Steinbrech D.S., Hsu M., Longaker M.T. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plastic and Reconstructive Surgery 2001, 108:423-429.
5. Colwell A.S., Longaker M.T., Lorenz H.P. Fetal wound healing. Frontiers in Bioscience 2003, 8:1240-1248.
6. Cowin A.J., Holmes T.M., Brosnan P., Ferguson M.W. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. European Journal of Dermatology 2001, 11:424-431.
7. Dalkowski A., Schuppan D., Orfannos C.E., Zouboulis C.C. Increased expression of tenascin C by keloids in vivo and in vitro. British Journal of Dermatology 1999, 141:50-56.
8. De Martin I., Theoret C.L. Spatial and temporal expression of types I and II receptors for transforming growth factor beta in normal equine skin and dermal wounds. Veterinary Surgery 2004, 33:70-76.
9. Ferguson M.W., O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philosophical Transactions of the Royal Society of London B: Biological Sciences 2004, 359:839-850.
10. Gosiewska A., Yi C.F., Brown L.J., Cullen B., Silcock D., Geesin J.C. Differential expression and regulation of extracellular matrix-associated genes in fetal and neonatal fibroblasts. Wound Repair and Regeneration 2001, 9:213-222.
11. Haber M., Cao Z., Panjwani N., Bedenice D., Li W.W., Provost P.J. Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing. Veterinary Ophthalmology 2003, 6:211-217.
12. Hildebrand A., Romaris M., Rasmussen L.M., Heinegard D., Twardzik D.R., Border W.A., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochemical Journal 1994, 302:527-534.
13. Iqbal J., Bird J.L., Hollander A.P., Bayliss M.T. Effect of matrix depleting agents on the expression of chondrocyte metabolism by equine chondrocytes. Research in Veterinary Science 2004, 77:249-256.
14. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., Tweed C., Martin W., Fornwald J., Lehr R., Harling J., Gaster L., Callahan J.F., Olson B.A. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Molecular Pharmacology 2002, 62:58-64.
15. Lee H.G., Eun H.C. Differences between fibroblasts cultured from oral mucosa and normal skin: implication to wound healing. Journal of Dermatological Science 1999, 21:176-182.
16. Lepault E., Celeste C., Dore M., Martineau D., Theoret C.L. Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair Regeneration 2005, 13:520-529.
17. Martinez E.F., Araujo V.C. In vitro immunoexpression of extracellular matrix proteins in dental pulpal and gingival human fibroblasts. International Endodontic Journal 2004, 37:749-755.
18. Millard C.J., Ellis I.R., Pickford A.R., Schor A.M., Schor S.L., Campbell I.D. The role of the fibronectin IGD motif in stimulating fibroblast migration. Journal of Biological Chemistry 2007, 282:35530-35535.
19. Miragliotta V., Lefebvre-Lavoie J., Lussier J.G., Theoret C.L. OB-cadherin cloning and expression in a model of wound repair in horses. Equine Veterinary Journal 2008, 40:643-648.
20. Nash D.M., Sheldon I.M., Herath S., Lane E.A. Markers of the uterine innate immune response of the mare. Animal Reproduction Science 2010 Mar, 119:31-39.
21. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 2002, 30:e36.
22. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000, 365-386. Humana Press, Totowa, NJ. S. Krawetz, S. Misener (Eds.).
23. Schmidbauer S.M., Venner M., von Samson-Himmelstjerna G., Drommer W., Gruber A.D. Compensated overexpression of procollagens alpha 1 (I) and alpha 1 (III) following perilla mint ketone-induced acute pulmonary damage in horses. Journal of Comparative Pathology 2004, 131:186-198.
24. Soo C., Hu F.Y., Zhang X., Wang G.Y., Beanes S.R., Lorenz H.P., Hedrick M.H., Mackpool R.J., Plaas A., Kim S.J., Longaker M.T., Freymiller E., Ting K. Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. American Journal of Pathology 2000, 157:423-433.
25. Szpaderska A.M., Zuckerman J.D., Dipietro L.A. Differential injury responses in oral mucosal and cutaneous wounds. Journal of Dental Research 2003, 82:621-626.
26. Theoret C.L. The pathophysiology of wound repair. Veterinary Clinics of North America: Equine Practice 2005, 21:1-13.
27. Theoret C.L., Barber S.M., Moyana T.N., Gordon J.R. Preliminary observations on expression of transforming growth factors beta1 and beta3 in equine full-thickness skin wounds healing normally or with exuberant granulation tissue. Veterinary Surgery 2002, 31:266-273.
28. Trebaul A., Chan E.K., Midwood K.S. Regulation of fibroblast migration by tenascin C. Biochemical Society Transactions 2007, 35:695-697.
29. Vogel K.G., Trotter J.A. The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. Collagen Related Research 1987, 7:105-114.
30. Warburton G., Nares S., Angelov N., Brahim J.S., Dionne R.A., Wahl S.M. Transcriptional events in a clinical model of oral mucosal tissue injury and repair. Wound Repair Regeneration 2005, 13:19-26.
31. Watts E.J., Rose M.T. Platelet-derived growth factor acts via both the Rho-kinase and p38 signaling enzymes to stimulate contraction in an in vitro. Domest Animal Endocrinology 2010, 38:253-259.
32. Whitby D.J., Ferguson M.W. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991, 112:651-668.
33. Wilmink J.M., Van Weeran P.R. Second-intention repair in the horse and pony and management of exuberant granulation tissue. Veterinary Clinics of North America Equine Practice 2005, 21:15-32.